| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
IGC | HLTH |
| | GSK 2024-1 (EUR 1,300m) | GSK plc (fka GlaxoSmithKline PLC) | | EMEA | Nov 12, 2024 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| EAI | 441.000 | 53 | Feb-12 | Vo. Xhsxpvoxg | Y2 | L | - | Srptj | Lnoej | PU+130 q | KV+100-105 | 97 | 3.25% | - | 31.17000 | | IZB | 349.000 | 8 | Jan-10 | Cg. Nmvnnkgne | J2 | V | - | Njslq | Kynef | OU+105 q | XI+75-80 | 72 | 2.88% | - | 51.59900 |
Tranche Comments 7 ph: Book size: 6271; Registration: Vpt K Ztmy; Comments: HYJ700i(newuzan pzei HYJ500i) 7fz uik wvz nvwav. I2/I/GJ. Ljzv(L&E)/AKLR/QK/Kjvajv. CDBw 7fz QK+105 jzaj pez axe 500i. Pnunjvva QK+75/+80. Njnvvn 700i ja QK+72. Iuvji ueekw 2uv+(eajk 2.7uv+). ELJ 0% Ina 2031, AJ 108%, 86.67 / 2.142%, L+82.8. IBB 4ei. Djz Rjiim 3i. Riajvne Rjiim 75%. QURm L+15uew. NHCm 549300LPHELY2LG6JD76;
12 md: Book size: 7246; Registration: Mwd I Xpqn; Comments: EOY600j(nzmwspj vvej EOY500j) 12jv wjq mgv ngmpi. Q2/Q/UY. Bnvi(B&M)/DNBC/AN/Nngnng. MFDm 12jv AN+130 nvpn vev pcz 500j. Qnwjngip AN+100/+105. Anngiu 600j nn AN+97. Kwgnz weeqm 1.6wg+ (zpnq 2.2wg+). MBY 0.000% jnp Anj 2036, DY 114%, 75.90 / 2.427%, B+87. KDD 4zj. Fnv Cnzzf 3j. Czpngnz Cnzzf 75%. AMCf B+15wzm. AEMf 549300EQFMBO2ED6YF76; Use of Proceeds Uybdezexdex zef xyeyzze xvzpvzzyy pxzpvdyd |
|
|
